Option Care Health (MM6A) Price & Analysis

Compare

0 Followers

MM6A Stock Chart & Stats

€28.40

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€28.40

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€22.20 - €32.40

Previous CloseN/A

Volume0.00

Average Volume (3M)25.00

Market Cap

€4.75B

Enterprise Value€6.71B

Total Cash (Recent Filing)€309.82M

Total Debt (Recent Filing)€1.28B

Price to Earnings (P/E)24.9

Beta0.54

Next Earnings

Feb 24, 2026

EPS Estimate

0.4

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.38

Shares Outstanding158,732,710

10 Day Avg. Volume0

30 Day Avg. Volume25

Financial Highlights & Ratios

PEG Ratio-1.08

Price to Book (P/B)2.83

Price to Sales (P/S)0.80

P/FCF Ratio13.83

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€32.62

Price Target Upside14.87% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering9

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Market Positioning And Demand DriversOption Care Health's scale in home and alternate-site infusion, strong payer relationships, and exposure to demographic and lower-cost care-setting trends position the company to capture higher growth and drive adjusted EBITDA expansion.

Product DiversificationAnalysts note that a substantial reduction in reliance on a single therapy materially de-risks Option Care Health's product portfolio, supporting potential for resumed revenue growth and margin expansion.

Share Repurchases And Capital AllocationBoard approval of a materially increased share repurchase authorization signals confidence in cash flow and creates capacity for continued buybacks and small strategic acquisitions that support shareholder returns.

Bears Say

Biosimilar Competition And Pricing PressureEmerging biosimilars and pricing changes are expected to act as a headwind to revenue and gross profit, creating pressure on margins even if the affected product is a small share of total sales.

Pharmacological Pipeline And Economic Policy UncertaintyUncertainty from the evolving pharmacological pipeline and broader economic policy risks could lead to intermittent revenue disruptions and complicate longer-term planning.

Policy-related Reimbursement RiskPricing pressure tied to legislation and policy shifts could reduce gross profits and introduce ongoing uncertainty for reimbursement and revenue trends.

Option Care Health News

Option Care Health price target raised to $37 from $27 at TD Cowen

TD Cowen raised the firm’s price target on Option Care Health (OPCH) to $37 from $27 and keeps...

21d ago

OPCH

Option Care Health price target raised to $42 from $38 at Barrington

Barrington analyst Michael Petusky raised the firm’s price target on Option Care Health (OPCH) to $42 from $38...

1M ago

OPCH

Option Care Health: Resilient Core Growth, Structural Tailwinds, and Capital Allocation Support Buy Rating

In a report released today, Joanna Gajuk from Bank of America Securities reiterated a Buy rating on Option...

1M ago

OPCH

Option Care Health price target raised to $38 from $36 at Citizens

Citizens raised the firm’s price target on Option Care Health (OPCH) to $38 from $36 and keeps an...

1M ago

OPCH

Closing Bell Movers: Revvity up 9% on strong outlook

Escalating tensions between the White House and the Federal Reserve – whereby an investigation of Powell over his...

1M ago

DAL

Option Care Health Issues 2025 Results and 2026 Outlook

Option Care Health ( ($OPCH) ) just unveiled an announcement. On January 12, 2026, Option Care Health released...

1M ago

OPCH

Option Care Health raises FY25 adjusted EPS view to $1.72-$1.76 from $1.68-$1.72

Consensus $1.72. Raises FY25 revenue view to $5.65B-$5.66B from $5.6B-$5.65B, consensus $5.64B. Narrows FY26 adjusted EBITDA view to...

1M ago

OPCH

Option Care Health sees FY26 adjusted EPS $1.82-$1.92, consensus $1.88

Sees FY26 revenue $5.8B-$6B, consensus $6.06B. Sees FY26 adjusted EBITDA $480M-$505M. Published first on TheFly – the ultimate...

1M ago

OPCH

Option Care Health increases share repurchase program to $1B

The company’s board of directors approved an increase to its 2025 share repurchase program authorization, from $500M to...

1M ago

OPCH

Option Care Health sees Q4 adjusted EPS 46c-49c, consensus 46c

Sees Q4 revenue $1.46B-$1.47B, consensus $1.46B. Sees Q4 adjusted EBITDA $123.7M-$127.7M. Published first on TheFly – the ultimate...

1M ago

OPCH

3 Strong Buy Stocks with a ‘Perfect 10’ Smart Score Right Now

Amid global market ups and downs, TipRanks provides useful tools to help investors make decisions. One of its...

2M ago

IAC

MTDR

Stephens starts Option Care Health at Overweight based on value chain position

As previously reported, Stephens initiated coverage of Option Care Health (OPCH) with an Overweight rating and $40 price...

2M ago

OPCH

Option Care Health initiated with an Overweight at Stephens

Stephens initiated coverage of Option Care Health (OPCH) with an Overweight rating and $40 price target Published first...

2M ago

OPCH

Option Care Health: Strong Growth Prospects and Strategic Initiatives Drive Buy Rating

Joanna Gajuk, an analyst from Bank of America Securities, reiterated the Buy rating on Option Care Health. The...

2M ago

OPCH

MM6A FAQ

What was Option Care Health Inc’s price range in the past 12 months?

Option Care Health Inc lowest stock price was €22.20 and its highest was €32.40 in the past 12 months.

What is Option Care Health Inc’s market cap?

Option Care Health Inc’s market cap is €4.75B.

When is Option Care Health Inc’s upcoming earnings report date?

Option Care Health Inc’s upcoming earnings report date is Feb 24, 2026 which is in 7 days.

How were Option Care Health Inc’s earnings last quarter?

Option Care Health Inc released its earnings results on Oct 30, 2025. The company reported €0.38 earnings per share for the quarter, beating the consensus estimate of €0.363 by €0.017.

Is Option Care Health Inc overvalued?

According to Wall Street analysts Option Care Health Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Option Care Health Inc pay dividends?

Option Care Health Inc does not currently pay dividends.

What is Option Care Health Inc’s EPS estimate?

Option Care Health Inc’s EPS estimate is 0.4.

How many shares outstanding does Option Care Health Inc have?

Option Care Health Inc has 158,732,710 shares outstanding.

What happened to Option Care Health Inc’s price movement after its last earnings report?

Option Care Health Inc reported an EPS of €0.38 in its last earnings report, beating expectations of €0.363. Following the earnings report the stock price went up 0.826%.

Which hedge fund is a major shareholder of Option Care Health Inc?

Currently, no hedge funds are holding shares in DE:MM6A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Option Care Health Stock Smart Score

Neutral

Fundamentals

Return on Equity

15.02%

Trailing 12-Months

Asset Growth

1.52%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Option Care Health Inc

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Option Care Health (MM6A) Earnings & Revenues

Historic Earnings Reports

MM6A Company Deck

MM6A Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Option Care Health's earnings call showcased strong revenue growth and raised guidance, driven by expansion in infusion services and effective capital management. However, the impact of Stelara biosimilars and pressure on gross margins posed challenges.View all DE:MM6A earnings summaries

MM6A Stock 12 Month Forecast

Average Price Target

€32.62

▲(14.87% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"€21","36":"€36","24.75":"€24.8","28.5":"€28.5","32.25":"€32.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35.39423286,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€35.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.6216846193,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€32.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.33791388,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€30.34</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,24.75,28.5,32.25,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28,28.568787143076925,29.137574286153846,29.70636142923077,30.275148572307693,30.843935715384617,31.41272285846154,31.981510001538464,32.550297144615385,33.11908428769231,33.687871430769235,34.25665857384615,34.82544571692308,{"y":35.39423286,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28,28.355514201484617,28.71102840296923,29.066542604453847,29.42205680593846,29.777571007423077,30.13308520890769,30.488599410392307,30.84411361187692,31.199627813361538,31.55514201484615,31.910656216330768,32.26617041781538,{"y":32.6216846193,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28,28.17983952923077,28.359679058461538,28.539518587692307,28.719358116923075,28.899197646153844,29.079037175384613,29.258876704615385,29.438716233846154,29.618555763076923,29.798395292307692,29.97823482153846,30.15807435076923,{"y":30.33791388,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":29.8,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.4,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.8,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.2,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.8,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.8,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >